No products in the cart.
Return To ShopNo products in the cart.
Return To ShopNo products in the cart.
Return To Shopanabolicdirectplus.com
No products in the cart.
Return To ShopSR-9009, commonly known as Stenabolic, is a synthetic compound developed to engage the Rev-ErbA protein. This revolutionary drug is touted for its potential in enhancing endurance and aiding weight management. Stenabolic operates at a molecular level, promoting mitochondrial biogenesis and optimizing the body’s metabolic processes. Often categorized within Selective Androgen Receptor Modulators (SARMs), SR-9009 is designed to emulate the benefits of an intense workout while mitigating the drawbacks of traditional performance enhancers.
The effectiveness of SR-9009 (Stenabolic) lies in its carefully formulated composition. Understanding the components is essential for assessing its therapeutic value.
These ingredients collectively contribute to the primary functionalities of SR-9009, enhancing its appeal among fitness enthusiasts and those seeking metabolic assistance.
While the benefits of SR-9009 (Stenabolic) are compelling, potential users should remain informed about its safety profile. The lack of extensive clinical trials necessitates caution when considering this compound.
The above safety information highlights the necessity for user vigilance and underscores the importance of professional guidance when utilizing SR-9009 (Stenabolic).
The therapeutic action of SR-9009 (Stenabolic) is primarily attributed to its role as a Rev-ErbA ligand. This engagement leads to multifaceted benefits, particularly for athletes and those pursuing fitness.
Understanding these benefits provides users with a clear picture of how SR-9009 could fit into their overall health and fitness strategy.
Implementing SR-9009 (Stenabolic) into a wellness regimen requires attention to dosage and duration.
By adhering to these guidelines, users can maximize the efficacy of SR-9009 (Stenabolic) while minimizing potential risks associated with unregulated use.
| Active substance | Stenabolic |
|---|---|
| Dosage | 20 Mg |
| Water Retention | No significant water retention |
| Hepatotoxicity | Not enough data to determine |
| Lab Test | Specific tests for detection in blood or urine not widely detailed |
| Also known as | SR9009, Stenabolic |
| Blood pressure | No significant impact reported |
| Trade name | Not available under any trade name as it is not commercially marketed |
| FORM | Oral |
| Dosage Unit | Tabs |
| ean13 | 1376635748334 |
| Reference | SPC08 |
| Tab Piece | 90 Tabs |
| Storage conditions | Store at room temperature away from moisture and light |
| Chemical name | Ethyl 3-[[(4-chlorobenzyl)((5-nitrothiophen-2-yl)methyl)amino]methyl]pyrrolidine-1-carboxylate |
| Formula | C20H24ClN3O4S |
| Substance class | Synthetic drug, Rev-ErbA ligand |
| Main action | Activates Rev-ErbA which increases mitochondrial count in muscle, decreases fat storage |
| Half-life | Approximately 4-5 hours |
| Dosage (medical) | Not clinically approved for medical use |
| Dosage (sports) | Typically 10-40 mg per day |
| Effects | Increased endurance, reduced fat mass, increased wakefulness |
| Side effects | Potential alterations in circadian rhythms, limited data on long-term effects |
| Use in sports | Used as a performance-enhancing drug, not approved by WADA |
| Packing | Bottle |
€114.00
Select at least 2 products
to compare
Reviews
There are no reviews yet.